These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11217404)

  • 1. Vaccines against hantaviruses.
    Hooper JW; Li D
    Curr Top Microbiol Immunol; 2001; 256():171-91. PubMed ID: 11217404
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.
    Kamrud KI; Hooper JW; Elgh F; Schmaljohn CS
    Virology; 1999 Oct; 263(1):209-19. PubMed ID: 10544095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
    de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
    J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins.
    Lindkvist M; Lahti K; Lilliehöök B; Holmström A; Ahlm C; Bucht G
    Vaccine; 2007 Feb; 25(9):1690-9. PubMed ID: 17110000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against hantaviruses.
    Hjelle B
    Expert Rev Vaccines; 2002 Oct; 1(3):373-84. PubMed ID: 12901576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice.
    Geldmacher A; Schmaler M; Krüger DH; Ulrich R
    Viral Immunol; 2004; 17(1):115-22. PubMed ID: 15018668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model.
    Ulrich R; Lundkvist A; Meisel H; Koletzki D; Sjölander KB; Gelderblom HR; Borisova G; Schnitzler P; Darai G; Krüger DH
    Vaccine; 1998; 16(2-3):272-80. PubMed ID: 9607042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pathogenic hantaviruses and prevention of infection.
    Krüger DH; Schönrich G; Klempa B
    Hum Vaccin; 2011 Jun; 7(6):685-93. PubMed ID: 21508676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baited vaccines: A strategy to mitigate rodent-borne viral zoonoses in humans.
    Mendoza EJ; Warner B; Kobinger G; Ogden NH; Safronetz D
    Zoonoses Public Health; 2018 Sep; 65(6):711-727. PubMed ID: 29931738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological diagnosis with recombinant N antigen for hantavirus infection.
    Yoshimatsu K; Arikawa J
    Virus Res; 2014 Jul; 187():77-83. PubMed ID: 24487183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hantaviruses in the Czech Republic.
    Pejcoch M; Kríz B
    Emerg Infect Dis; 2003 Jun; 9(6):756-7. PubMed ID: 12781027
    [No Abstract]   [Full Text] [Related]  

  • 14. An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice.
    Geldmacher A; Skrastina D; Petrovskis I; Borisova G; Berriman JA; Roseman AM; Crowther RA; Fischer J; Musema S; Gelderblom HR; Lundkvist A; Renhofa R; Ose V; Krüger DH; Pumpens P; Ulrich R
    Virology; 2004 May; 323(1):108-19. PubMed ID: 15165823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica.
    Elgh F; Linderholm M; Wadell G; Tärnvik A; Juto P
    FEMS Immunol Med Microbiol; 1998 Dec; 22(4):309-15. PubMed ID: 9879922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge.
    Klingström J; Maljkovic I; Zuber B; Rollman E; Kjerrström A; Lundkvist A
    Vaccine; 2004 Sep; 22(29-30):4029-34. PubMed ID: 15364453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.
    Salonen EM; Parren PW; Graus YF; Lundkvist A; Fisicaro P; Vapalahti O; Kallio-Kokko H; Vaheri A; Burton DR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():659-65. PubMed ID: 9568958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex ecology of hantavirus in Paraguay.
    Chu YK; Owen RD; Gonzalez LM; Jonsson CB
    Am J Trop Med Hyg; 2003 Sep; 69(3):263-8. PubMed ID: 14628942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.